 |
|
Alcohol-deterrent drugs help patients achieve high rates of long-term abstinence
January 04, 2006A nine-year study looks at the impact of "alcohol deterrents" (ADs) disulfiram and calcium carbimide.
- Researchers found an abstinence rate of more than 50 percent among the patients studied.
- ADs appear to play a major psychological role in relapse prevention.
Studies investigating the long-term outcomes of alcoholism treatment are rare and inconsistent. A nine-year study in the January issue of Alcoholism: Clinical & Experimental Research investigates the occurrence of abstinence, lapse, and relapse among chronic alcoholics while exploring the role that "alcohol deterrents" (ADs) - specifically, disulfiram and calcium carbimide - may play. Results indicate that ADs can help achieve an abstinence rate of more than 50 percent.
"Although up to 30 percent of patients may claim to be abstinent two to three years after treatment," said Hannelore Ehrenreich, head of the division of clinical neuroscience at the Max-Planck-Institute of Experimental Medicine in Germany and corresponding author for the study, "objective laboratory data indicate that only six to 20 percent of patients are abstinent two years after therapy. These results reflect therapists' clinical experience that alcoholism is a chronic and relapsing disease similar to other chronic conditions such as hypertension or diabetes, and should be accepted as a disorder that requires long-term or life-long treatment. This study is the first report on supervised, long-term administration of ADs, with a focus on the psychological rather than the pharmacological action of ADs."
Alcohol deterrents seem to be more widely accepted and used in Europe than they are in North America, said Colin Brewer, research director of the Stapleford Centre in London. "I have co-authored a study showing that the three 'Anglo-Saxon' countries examined - the U.K, U.S. and New Zealand - had the lowest use," he said. "Furthermore, a recent U.S. study showed that addiction specialists prescribed disulfiram or naltrexone for fewer than 15 percent of their alcoholic patients. Conversely, disulfiram use is certainly common in Spain, Portugal, Germany, Austria and Scandinavia."
Researchers analyzed data gathered from 1993 to 2002, when 180 chronic alcoholics were consecutively admitted to a two-year comprehensive integrated treatment program called the Outpatient Longterm Intensive Therapy for Alcoholics (OLITA). Carefully prepared and supervised intake of disulfiram or calcium carbimide is a major component of the program. Given that an earlier study showed that 30 OLITA patients achieved higher abstinence rates than case controls in other programs, the authors wanted to extend their investigation to all 180 patients for seven years following treatment, with a specific focus on the role of disulfiram or calcium carbimide in relapse prevention and maintenance of long-term abstinence.
"We found an abstinence rate of more than 50 percent among the patients studied," said Ehrenreich. "Long-term use of ADs appeared to be well-tolerated. Abstinence rates were better in patients who stayed on alcohol deterrents for more than 20 months as compared to patients who terminated intake at 13 to 20 months."
Ehrenreich said that the data imply a psychological rather than a pharmacological action of ADs. "First, the longer the intake, the more likely is a patient to stay continuously abstinent even after termination of ADs," she said. "Second, the dose of ADs is as irrelevant as the experience of a subsequent reaction for ADs to be effective. Third, sham-ADs are as efficient as disulfiram or calcium carbimide, provided that the use is repeatedly explained and continuously guided and encouraged."
"The psychological role that ADs may play in relapse prevention is one of the most interesting aspects of the study," added Brewer. "These results support the theory that prolonged abstinence achieved with disulfiram automatically leads to the consolidation of the habit of abstinence. Practice makes perfect. The longer people abstain, the longer they will abstain. In addition, deterrent drugs clearly do deter. Supposedly deterrent drugs also deter but they only deter because there is a real pharmacological reaction. The analogy here is with speed cameras. We know that inactive cameras also deter but only because drivers can't know they are inactive unless they put them to the test. In both contexts, people are reluctant to make the experiment."
Although ADs are the focus of this study, said Ehrenreich, other treatment components of the OLITA program are just as important, and help to explain the psychological role that ADs play in relapse prevention. "These include strict abstinence orientation, high frequency short-term individual contacts, supportive, non-confronting counselling, therapist rotation, emergency service and crisis interventions, social re-integration, long-term treatment and subsequent life-long check-up visits, as well as a concept that recognizes 'alcohol relapse' as an emergency," she said. "Related to this relapse model, we developed what we call 'aggressive aftercare,' consisting of therapeutic interventions to immediately interrupt beginning, and prevent threatening, relapses. Patients who miss a therapeutic contact are contacted through spontaneous house visits, telephone calls or mail to continue therapy or to restart abstinence."
"Supervision may seem labour-intensive," observed Brewer, "but if the labour is already there, as it is in the clinic, or if one can involve family, workmates or probation services in supervision, as should be routine, it needs no extra resources. Supervised disulfiram may be particularly effective in patients who have not responded to conventional treatments. We urgently need an effective disulfiram implant, for the same reasons that naltrexone implants have been developed. There should also be more trials of probation-linked disulfiram, since alcohol-related crime is a very important issue. This study suggests that if alcoholic offenders take disulfiram regularly, even reluctantly, they will not get drunk if the dose is adequate. That should revolutionize the management of such offenders. Similar trials with naltrexone in heroin-related offenders have been very effective with no negative results."
"Our results support a major clinical implication," said Ehrenreich, "that severe alcoholism is a chronic and relapsing disease. Only long-term treatment, followed by life-long attending of check-up sessions and self-help group participation will guarantee long-term recovery. Supervised intake of ADs can easily and successfully be integrated into a comprehensive and structured outpatient long-term treatment program. The strategy of deterrence works if therapists disengage from the emphasis of pharmacological effects of disulfiram and make full use of the psychological actions of this drug."
Alcoholism: Clinical & Experimental Research (ACER)
Studies investigating the long-term outcomes of alcoholism treatment are rare and inconsistent. A nine-year study in the January issue of Alcoholism: Clinical & Experimental Research investigates the occurrence of abstinence, lapse, and relapse among chronic alcoholics while exploring the role that "alcohol deterrents" (ADs) - specifically, disulfiram and calcium carbimide - may play. Results indicate that ADs can help achieve an abstinence rate of more than 50 percent.
"Although up to 30 percent of patients may claim to be abstinent two to three years after treatment," said Hannelore Ehrenreich, head of the division of clinical neuroscience at the Max-Planck-Institute of Experimental Medicine in Germany and corresponding author for the study, "objective laboratory data indicate that only six to 20 percent of patients are abstinent two years after therapy. These results reflect therapists' clinical experience that alcoholism is a chronic and relapsing disease similar to other chronic conditions such as hypertension or diabetes, and should be accepted as a disorder that requires long-term or life-long treatment. This study is the first report on supervised, long-term administration of ADs, with a focus on the psychological rather than the pharmacological action of ADs."
Alcohol deterrents seem to be more widely accepted and used in Europe than they are in North America, said Colin Brewer, research director of the Stapleford Centre in London. "I have co-authored a study showing that the three 'Anglo-Saxon' countries examined - the U.K, U.S. and New Zealand - had the lowest use," he said. "Furthermore, a recent U.S. study showed that addiction specialists prescribed disulfiram or naltrexone for fewer than 15 percent of their alcoholic patients. Conversely, disulfiram use is certainly common in Spain, Portugal, Germany, Austria and Scandinavia."
Researchers analyzed data gathered from 1993 to 2002, when 180 chronic alcoholics were consecutively admitted to a two-year comprehensive integrated treatment program called the Outpatient Longterm Intensive Therapy for Alcoholics (OLITA). Carefully prepared and supervised intake of disulfiram or calcium carbimide is a major component of the program. Given that an earlier study showed that 30 OLITA patients achieved higher abstinence rates than case controls in other programs, the authors wanted to extend their investigation to all 180 patients for seven years following treatment, with a specific focus on the role of disulfiram or calcium carbimide in relapse prevention and maintenance of long-term abstinence.
"We found an abstinence rate of more than 50 percent among the patients studied," said Ehrenreich. "Long-term use of ADs appeared to be well-tolerated. Abstinence rates were better in patients who stayed on alcohol deterrents for more than 20 months as compared to patients who terminated intake at 13 to 20 months."
Ehrenreich said that the data imply a psychological rather than a pharmacological action of ADs. "First, the longer the intake, the more likely is a patient to stay continuously abstinent even after termination of ADs," she said. "Second, the dose of ADs is as irrelevant as the experience of a subsequent reaction for ADs to be effective. Third, sham-ADs are as efficient as disulfiram or calcium carbimide, provided that the use is repeatedly explained and continuously guided and encouraged."
"The psychological role that ADs may play in relapse prevention is one of the most interesting aspects of the study," added Brewer. "These results support the theory that prolonged abstinence achieved with disulfiram automatically leads to the consolidation of the habit of abstinence. Practice makes perfect. The longer people abstain, the longer they will abstain. In addition, deterrent drugs clearly do deter. Supposedly deterrent drugs also deter but they only deter because there is a real pharmacological reaction. The analogy here is with speed cameras. We know that inactive cameras also deter but only because drivers can't know they are inactive unless they put them to the test. In both contexts, people are reluctant to make the experiment."
Although ADs are the focus of this study, said Ehrenreich, other treatment components of the OLITA program are just as important, and help to explain the psychological role that ADs play in relapse prevention. "These include strict abstinence orientation, high frequency short-term individual contacts, supportive, non-confronting counselling, therapist rotation, emergency service and crisis interventions, social re-integration, long-term treatment and subsequent life-long check-up visits, as well as a concept that recognizes 'alcohol relapse' as an emergency," she said. "Related to this relapse model, we developed what we call 'aggressive aftercare,' consisting of therapeutic interventions to immediately interrupt beginning, and prevent threatening, relapses. Patients who miss a therapeutic contact are contacted through spontaneous house visits, telephone calls or mail to continue therapy or to restart abstinence."
"Supervision may seem labour-intensive," observed Brewer, "but if the labour is already there, as it is in the clinic, or if one can involve family, workmates or probation services in supervision, as should be routine, it needs no extra resources. Supervised disulfiram may be particularly effective in patients who have not responded to conventional treatments. We urgently need an effective disulfiram implant, for the same reasons that naltrexone implants have been developed. There should also be more trials of probation-linked disulfiram, since alcohol-related crime is a very important issue. This study suggests that if alcoholic offenders take disulfiram regularly, even reluctantly, they will not get drunk if the dose is adequate. That should revolutionize the management of such offenders. Similar trials with naltrexone in heroin-related offenders have been very effective with no negative results."
"Our results support a major clinical implication," said Ehrenreich, "that severe alcoholism is a chronic and relapsing disease. Only long-term treatment, followed by life-long attending of check-up sessions and self-help group participation will guarantee long-term recovery. Supervised intake of ADs can easily and successfully be integrated into a comprehensive and structured outpatient long-term treatment program. The strategy of deterrence works if therapists disengage from the emphasis of pharmacological effects of disulfiram and make full use of the psychological actions of this drug."
Alcoholism: Clinical & Experimental Research (ACER)
Alcoholism Current Events and Alcoholism News RSSScripps team shows diet switching can activate brain's stress system, lead to 'withdrawal' symptoms
In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.
Drunken fruit flies help scientists find potential drug target for alcoholism
A group of drunken fruit flies have helped researchers from North Carolina State and Boston universities identify entire networks of genes-also present in humans-that play a key role in alcohol drinking behavior.
Pitt, US Army team designs new strategy to find drugs to treat neglected infection
Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases.
Alcohol activates cellular changes that make tumor cells spread
Alcohol consumption has long been linked to cancer and its spread, but the underlying mechanism has never been clear.
Taking medicine for HIV proves hard to swallow for many people
Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely difficult for many individuals to do.
Alcohol Tolerance Switch Found in Fruit Flies
Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol.
Alcoholism's effect on sleep persists during long periods of sobriety
A study in the Oct.1 issue of the journal Sleep shows that long-term alcoholism affects sleep even after long periods of abstinence, and the pattern of this effect is similar in both men and women.
New ways to predict violent behavior?
In the future, diagnosing severe personality disorders, evaluating the childhood environment, assessing alcohol consumption and the analysis of the MAOA genotype may provide more accurate means for assessing risk among violent offenders, according to the Finnish research carried out jointly at the University of Helsinki and the Helsinki University Central Hospital Psychiatry Centre.
Young age at first drink may affect genes and risk for alcoholism
The age at which a person takes a first drink may influence genes linked to alcoholism, making the youngest drinkers the most susceptible to severe problems.
Penn State College of Medicine research isolates liver cancer stem cells prior to tumor formation
Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer.
More Alcoholism Current Events and Alcoholism News Articles
 |
The Cure for Alcoholism: Drink Your Way Sober Without Willpower, Abstinence or Discomfort by Roy Eskapa PhD (Author), David Sinclair PhD (Foreword) Introducing a revolutionary solution to alcohol dependence, this study outlines the Sinclair Method, a treatment that combines the prescription medication Naltrexone and the continued consumption of alcohol. Already well known in many parts of Europe, this breakthrough remedy will bring relief to the millions who suffer from addiction or to those who are affected by someone else’s. Topics covered include the hard evidence behind the treatment, moving testimonials from cured alcoholics, interviews from clinics that have adopted the method, and details about Naltrexone. |
 |
Beyond the Influence: Understanding and Defeating Alcoholism by Katherine Ketcham (Author), William F. Asbury (Author), Mel Schulstad (Author), Arthur P. Ciaramicoli (Author) This invaluable work will contribute much to the battle against our number one disease." --from the Foreword by George McGovern, former senator and author of Terry: My Daughter's Life-and-Death Struggle with Alcoholism Alcoholism is a disease. It's time we started treating it like one. Science has offered undisputed proof that alcoholism is a disease rather than a weakness of character, yet millions of alcoholics continue to suffer due to inappropriate treatment. Now the co-author of the modern classic Under the Influence has teamed up with prominent alcoholism experts to provide new answers to this national epidemic. Based on the latest scientific research, Beyond the Influence clearly explains the neurological nature of the disease and reveals why some people... |
 |
Understanding the Alcoholic's Mind: The Nature of Craving and How to Control It by Arnold M. Ludwig (Author) In this groundbreaking book, Arnold M. Ludwig--a doctor with over twenty-five years of experience working with alcoholics--penetrates the minds of alcoholics in order to explain the behaviors and thought processes they use to get and stay sober. He has worked with over one thousand alcoholics from all walks of life and within many different settings, including hospital clinics, Alcoholics Anonymous meetings, detoxification centers, and private homes. Using clinical vignettes, research findings, and personal anecdotes, he documents the basic principles necessary for conquering craving and achieving recovery. |
 |
My Way Out: One Woman's Remarkable Journey in Overcoming Her Drinking Problem and How Her Innovative Program Can Help You or Someone You Love by Roberta Jewell (Author) Research indicates one out of 13 Americans suffers a drinking problem and four problem drinkers exist for every "hard core alcoholic". It is one of our country’s most significant health issues and a pervasive secret epidemic. Those affected are desperate for help but do not fit the alcoholic profile. So instead of seeking help, they suffer in silence. In My Way Out, Jewell describes her history as a highly functional alcoholic and her decades of research in battling her addiction. Written in collaboration with Dr. Linda Garcia, MD, the search ultimately led her to develop a program calling upon experts in multiple fields. Jewell’s therapy is based upon a 2002 double blind study published in The Lancet, a highly esteemed British medical journal, which reported results of... |
 |
Drinking: A Love Story by Caroline Knapp (Author) A journalist describes her twenty years as a functioning alcoholic, explaining how she used alcohol to escape the realities of life and personal relationships, until a series of personal crises forced her to confront her problem. Reprint. 90,000 first printing." |
 |
Under the Influence: A Guide to the Myths and Realities of Alcoholism by James Robert Milam (Author), Katherine Ketcham (Author) Ten of millions Americans suffer from alcoholism, yet most people still wrongly believe that alcoholism is a psychological or moral problem, and that it can be cured by psychotherapy or sheer will power. Based on groundbreaking scientific research, Under The Influence examine the physical factors that set alcoholics and non-alcoholics apart, and suggests a bold, stigma-free way of understanding and treating the alcoholic. How to tell if someone you know is an alcoholic. The progressive stages of alcoholism. How to get an alcoholic into treatment -- and how to choose a treatment program. Why frequently prescribed drugs can be dangerous -- even fatal -- for alcoholics. How to ensure a lasting recovery. |
 |
Seven Weeks to Sobriety: The Proven Program to Fight Alcoholism through Nutrition by Joan Mathews Larson (Author) "Comprehensive, rational and personal. It suppplies much of what is missing in traditional approaches to alcoholic rehabilitation. I believe that this book can save lives." Leo Galland, M.D. Open this book and you will embark on a groundbreaking seven-week journey that will change your life. You will learn how to break your addiction to alcohol and end your cravings--and do it under your own power. Here, step-by-step, is a proven, seven-week program developed by Dr. Joan Matthews Larson at the innovative Health Recovery Center in Minneapolis, that subdues your body's addictive chemistry and puts you on the path to full recovery. |
 |
THE ALCOHOLISM AND ADDICTION CURE: A Holistic Approach to Total Recovery by Chris Prentiss (Author) The breakthrough three-step program to total recovery from addiction to drugs, alcohol and addictive behaviors. Reveals the four causes of dependency and shows how to create a personalized , holistic treatment program to completely cure your dependency. |
 |
Marriage On The Rocks: Learning to Live with Yourself and an Alcoholic by Janet G. Woititz (Author) From the author of the New York Times bestseller Adult Children of Alcoholics -- an invaluable guide for women dealing with alcoholic partners. |
 |
The Easy Way to Stop Drinking by Allen Carr (Author) Carr offers a startling new view of why we drink and how we can escape the addiction. Step by step, with devastating clarity and simplicity, he applies the Easyway™ method, dispelling all the illusions that surround the subject of drinking and that can make it almost impossible to imagine a life without alcohol. Only when we step away from all these supposed pleasures and understand how we are being duped to believe we are receiving real benefits can we begin to live our lives free from any desire or need for drinking. The Easyway™ method centers on removing the psychological need to drink—while the drinker is still drinking. Following the Easyway™:• You will not need willpower• You will not feel deprived• You will lose your fear of withdrawal pangs• You will enjoy social... |
| © 2009 BrightSurf.com |